vs
Side-by-side financial comparison of Bloom Energy Corp (BE) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $751.1M, roughly 1.5× Bloom Energy Corp). Bloom Energy Corp runs the higher net margin — 9.4% vs -127.8%, a 137.2% gap on every dollar of revenue. On growth, Bloom Energy Corp posted the faster year-over-year revenue change (130.4% vs -2.5%). Over the past eight quarters, Bloom Energy Corp's revenue compounded faster (51.7% CAGR vs 1.3%).
KR Sridhar is an Indian American engineer, inventor, professor, and entrepreneur. He is the founder, chairman, and chief executive officer (CEO) of Bloom Energy. Prior, Sridhar was a professor of Aerospace and Mechanical Engineering and the Director of the Space Technologies Laboratory (STL) at the University of Arizona. He worked with and advised NASA, and is a member of the National Academy of Engineering.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
BE vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $751.1M | $1.1B |
| Net Profit | $70.7M | $-1.4B |
| Gross Margin | 30.0% | 32.6% |
| Operating Margin | 17.3% | -116.0% |
| Net Margin | 9.4% | -127.8% |
| Revenue YoY | 130.4% | -2.5% |
| Net Profit YoY | — | -3093.9% |
| EPS (diluted) | $0.44 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $751.1M | — | ||
| Q4 25 | $772.8M | $1.1B | ||
| Q3 25 | $513.3M | $1.0B | ||
| Q2 25 | $396.3M | $1.1B | ||
| Q1 25 | $319.3M | $1.0B | ||
| Q4 24 | $567.0M | $1.1B | ||
| Q3 24 | $321.8M | $1.1B | ||
| Q2 24 | $326.5M | $1.1B |
| Q1 26 | $70.7M | — | ||
| Q4 25 | $1.4M | $-1.4B | ||
| Q3 25 | $-23.0M | $7.5M | ||
| Q2 25 | $-42.2M | $-8.4M | ||
| Q1 25 | $-23.4M | $-6.4M | ||
| Q4 24 | $105.2M | $-44.4M | ||
| Q3 24 | $-14.6M | $-21.0M | ||
| Q2 24 | $-61.2M | $-108.4M |
| Q1 26 | 30.0% | — | ||
| Q4 25 | 31.0% | 32.6% | ||
| Q3 25 | 29.5% | 36.1% | ||
| Q2 25 | 27.0% | 34.4% | ||
| Q1 25 | 27.8% | 37.6% | ||
| Q4 24 | 38.7% | 33.9% | ||
| Q3 24 | 24.5% | 37.2% | ||
| Q2 24 | 21.0% | 37.0% |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 11.3% | -116.0% | ||
| Q3 25 | 1.5% | 7.0% | ||
| Q2 25 | -0.9% | 4.3% | ||
| Q1 25 | -6.0% | 4.5% | ||
| Q4 24 | 18.5% | 10.0% | ||
| Q3 24 | -3.0% | 7.4% | ||
| Q2 24 | -7.1% | -2.5% |
| Q1 26 | 9.4% | — | ||
| Q4 25 | 0.2% | -127.8% | ||
| Q3 25 | -4.5% | 0.7% | ||
| Q2 25 | -10.6% | -0.8% | ||
| Q1 25 | -7.3% | -0.6% | ||
| Q4 24 | 18.5% | -3.9% | ||
| Q3 24 | -4.5% | -1.9% | ||
| Q2 24 | -18.7% | -10.2% |
| Q1 26 | $0.44 | — | ||
| Q4 25 | $99.91 | $-10.23 | ||
| Q3 25 | $-100.00 | $0.05 | ||
| Q2 25 | $-0.18 | $-0.06 | ||
| Q1 25 | $-0.10 | $-0.05 | ||
| Q4 24 | $0.45 | $-0.32 | ||
| Q3 24 | $-0.06 | $-0.15 | ||
| Q2 24 | $-0.27 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $948.0K | $2.9B |
| Total Assets | $4.7B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $595.1M | $432.1M | ||
| Q2 25 | $574.8M | $454.2M | ||
| Q1 25 | $794.8M | $409.9M | ||
| Q4 24 | $802.9M | $558.8M | ||
| Q3 24 | $495.7M | $1.5B | ||
| Q2 24 | $581.7M | $542.8M |
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | $948.0K | — | ||
| Q4 25 | $768.6M | $2.9B | ||
| Q3 25 | $653.1M | $4.4B | ||
| Q2 25 | $594.6M | $4.5B | ||
| Q1 25 | $578.3M | $4.4B | ||
| Q4 24 | $562.5M | $4.3B | ||
| Q3 24 | $430.9M | $4.6B | ||
| Q2 24 | $423.3M | $4.5B |
| Q1 26 | $4.7B | — | ||
| Q4 25 | $4.4B | $8.5B | ||
| Q3 25 | $2.6B | $10.1B | ||
| Q2 25 | $2.5B | $10.1B | ||
| Q1 25 | $2.6B | $9.8B | ||
| Q4 24 | $2.7B | $9.6B | ||
| Q3 24 | $2.6B | $11.2B | ||
| Q2 24 | $2.5B | $10.4B |
| Q1 26 | — | — | ||
| Q4 25 | 3.41× | — | ||
| Q3 25 | 1.73× | — | ||
| Q2 25 | 1.91× | — | ||
| Q1 25 | 1.96× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.62× | — | ||
| Q2 24 | 2.66× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $418.1M | $175.4M | ||
| Q3 25 | $19.7M | $51.7M | ||
| Q2 25 | $-213.1M | $75.9M | ||
| Q1 25 | $-110.7M | $-64.5M | ||
| Q4 24 | $484.2M | $312.6M | ||
| Q3 24 | $-69.5M | $42.2M | ||
| Q2 24 | $-175.5M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | $395.1M | $148.6M | ||
| Q3 25 | $7.4M | $29.8M | ||
| Q2 25 | $-220.4M | $56.7M | ||
| Q1 25 | $-124.9M | $-90.0M | ||
| Q4 24 | $473.1M | $274.9M | ||
| Q3 24 | $-83.8M | $15.1M | ||
| Q2 24 | $-187.5M | $-18.9M |
| Q1 26 | — | — | ||
| Q4 25 | 51.1% | 13.4% | ||
| Q3 25 | 1.4% | 2.9% | ||
| Q2 25 | -55.6% | 5.4% | ||
| Q1 25 | -39.1% | -8.6% | ||
| Q4 24 | 83.4% | 24.2% | ||
| Q3 24 | -26.0% | 1.4% | ||
| Q2 24 | -57.4% | -1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | 2.4% | ||
| Q3 25 | 2.4% | 2.1% | ||
| Q2 25 | 1.8% | 1.8% | ||
| Q1 25 | 4.5% | 2.4% | ||
| Q4 24 | 2.0% | 3.3% | ||
| Q3 24 | 4.4% | 2.5% | ||
| Q2 24 | 3.7% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 293.18× | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.60× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BE
| Product | $653.3M | 87% |
| Service | $61.9M | 8% |
| Installation | $25.9M | 3% |
| Electricity | $9.9M | 1% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
